Delivery Order SPE2DB20D9214-SPE2DB25FD4XH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The products will be delivered to Park Ridge, Illinois and support the federal pharmaceutical supply chain...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a set-aside designation, allowing the vendor to compete in the open market while leveraging its...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, valued at $2,226.84, was executed on August 12, 2025, with an ultimate completion date of September 3, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis leveraging its small business...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a continuation of DLA's pharmaceutical supply operations through its broader procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $27,835.50 by the Defense Logistics Agency for YF-VAX 1 dose vials. The contract is firm fixed price with no set-aside designation, reflecting the company's competitive standing in federal procurement. The delivery order is set for ultimate completion by August 15, 2025, with performance to take place at the vendor's Park Ridge, Illinois...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order utilizes firm fixed-price pricing and represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for YF-VAX 1 dose vials with a ceiling value of $2,226.84. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 15, 2025, and will be performed at the vendor's Park Ridge location. The award falls under DMS Pharmaceutical...
- On August 12, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 3, 2025, and no set-aside designation was applied to this award....
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order, issued on August 19, 2025, requires performance at the contractor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis within the federal marketplace. DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,186.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The award, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- SPE2DB20D9214Indefinite Delivery Contract
- SPE2DB20D9214-SPE2DB25FD4XHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,268.40 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, is well-positioned to fulfill this requirement as a critical supplier within the federal pharmaceutical supply chain serving Department of Defense healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities worldwide. The company's established contract portfolio with DLA demonstrates consistent success in delivering diverse pharmaceutical products, including vaccines, injections, branded and generic medications, and specialty pharmaceuticals to support defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.3k | 8/27/25 |